Our research showed that a positive correlation existed between GSTP1 level and ALL treatment response and newly diagnosed ALL patients with higher relative intensity of GSTP1 peptide were prone to an earlier relapse. This evidence concerns the gene GSTP1 and acute lymphoblastic leukemia.